首页
登录
职称英语
A famous US climate scientist at the centre of the "climategate" has been vi
A famous US climate scientist at the centre of the "climategate" has been vi
游客
2023-09-05
41
管理
问题
A famous US climate scientist at the centre of the "climategate" has been virtually cleared of professional misconduct by an internal university inquiry. Michael Mann of Penn State University featured regularly in the more than 1 000 e-mails that were hacked from the University of East Angha (UEA) in the UK last November. His e-mails and comments have since then featured in countless blogs and news articles. Some have claimed the e-mails reveal that many climate scientists have changed data in order to demonstrate that climate change is caused by human activities. The scientists in the e-mails, including Mann, have also been accused of seeking to prevent the publication of doubting research in academic journals.
Penn State University opened an inquiry into Mann’s behavior in November, shortly after the e-mails were leaked into the public attention. After going through 1 075 e-mails and focusing on that were believed relevant to public idea of misconduct by Mann, the inquiry has, by and large, cleared his name. The internal inquiry has found that Mann did not participate in, directly or indirectly, any actions to hide or change data, nor did he remove or otherwise destroy e-mails, information and/or data relating to Climate Change’s 2007 report. One e-mail that has received much media attention was sent to Mann by Phil Jones, then director of the UEA’s Climatic Research Unit. It asked Mann to delete some e-mails regarding the 2007 IPCC report.
The report is not clear about whether Mann’s behavior has harmed the public trust in science. It cites Penn State’s official ethical standards, which says faculty have an obligation to maintain high moral standards in order to raise public trust in science. It then goes on to discuss the fallout from the e-mail leak which, it says, may have driven the public into two camps: one that believes the leak harms climate science and another that does not.
"After careful consideration of all the evidence and relevant materials, the inquiry committee could not make a definitive finding whether there exists any evidence to prove that Dr. Mann did engage in, or participate in, directly or indirectly, any actions against accepted academic practices," reads the report. This final point will now be at the centre of a further investigation.
"This is very much the proof I expected since I am confident I have done nothing wrong," Mann told NewScientist. "I fully support the additional inquiry which may be the best way to remove any remaining doubts." [br] Mann told NewScientist that he hoped to have more inquiry to______.
选项
答案
remove any remaining doubts
解析
细节归纳题。本题考查Mann欢迎更多的调查的原因。文中最后表明了Mann对该事件的态度,他对《新科学家》杂志说他欢迎更多的调查,因为这可能是澄清任何余留怀疑的最好方法。
转载请注明原文地址:https://www.tihaiku.com/zcyy/2988739.html
相关试题推荐
Scientistssaytheyhavehighhopesforadrugthatcouldonedayprovidean
Scientistssaytheyhavehighhopesforadrugthatcouldonedayprovidean
[originaltext](26)Scientistsclaimthatairpollutioncausesadeclinein
[originaltext](26)Scientistsclaimthatairpollutioncausesadeclinein
Everylivingthinghaswhatscientistscallabiologicalclockthatcontrol
Everylivingthinghaswhatscientistscallabiologicalclockthatcontrol
Everylivingthinghaswhatscientistscallabiologicalclockthatcontrol
Everylivingthinghaswhatscientistscallabiologicalclockthatcontrol
Everylivingthinghaswhatscientistscallabiologicalclockthatcontrol
Everylivingthinghaswhatscientistscallabiologicalclockthatcontrol
随机试题
Forthispart,youareallowed30minutestowriteacompositiononthetopic:H
[originaltext]Theearth’soceansarehuge,somuchbiggerthanthelandarea
[originaltext]W:Hey!(9)Areyougoingtoplaysometennisthisafternoon?M:W
某分部工程的网络计划见图5-3-1,计算工期为44天。根据技术方案,确定A、D、
对《实施条例》第49条第2款规定:机动车在没有禁止掉头或者没有禁止左转弯标志、标线的地点可以掉头,但不得妨碍正常行驶的其他车辆和行人的通行。
下列哪项不是从单一的健康体检、生活方式指导发展出来的新项目()A.全民健康促
有限合伙制私募基金的运作机制包括()。A.管理费及运营成本的控制 B.利益分
按照《上市公司并购重组财务顾问业务管理办法》规定,财务顾问主办人应该具备的条件不
常用的采暖方式包括()。A.集中采暖 B.局部采暖 C.区域供热 D
A.Ⅰ期临床试验 B.Ⅱ期临床试验 C.Ⅲ期临床试验 D.Ⅳ期临床试验病例
最新回复
(
0
)